Kawasaki disease

Archives of Disease in Childhood: Education and Practice Edition

Volumn 89, Issue 1, 2004, Pages

  Maconochie, Ian K ^a  

^a ST MARY S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; IMMUNOGLOBULIN; METHYLPREDNISOLONE; SALICYLIC ACID; STEROID;

CERVICAL LYMPH NODE; CLINICAL FEATURE; CLINICAL TRIAL; CONJUNCTIVA DISEASE; CORONARY ARTERY ANEURYSM; DESQUAMATION; DIFFERENTIAL DIAGNOSIS; FEVER; HUMAN; LYMPHADENOPATHY; META ANALYSIS; MOUTH DISEASE; MUCOCUTANEOUS LYMPH NODE SYNDROME; PERIPHERAL EDEMA; PRACTICE GUIDELINE; PRIORITY JOURNAL; RASH; REVIEW; SIDE EFFECT; SYSTEMATIC REVIEW;

EID: 3042517764     PISSN: 17430585     EISSN: None     Source Type: Journal    
DOI: 10.1136/adc.2004.053728     Document Type: Review

References (43)

1. Kawasaki T. Acute febrile mucocutaneous syndrome with lymphoid involvement with specific desquamation of the toes and fingers in children. Jpn J Allerg 1967;16:178-222.
2. American Heart Association Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease. Diagnostic guidelines for Kawasaki disease. Am J Dis Child 1990;144:1218-9.
3. Rowley AH, Gonzalez CF, Giding SS, et al. Incomplete Kawasaki disease with coronary artery involvement. J Pediatr 1987;110:409-13.
4. Harnden A, Alves B, Sheikh A. Rising incidence of Kawasaki disease in England: analysis of hospital admission data. BMJ 2002;342:1424-5.
5. Dhillon R, Newton L, Rudd PT, et al. Management of Kawasaki disease in the British Isles. Arch Dis Child 1993;69:631-8.
6. Royle JA, Williams K, Elliott E, et al. Kawasaki disease in Australia, 1993-95. Arch Dis Child 1998;78:33-9.
7. Yanagawa H, Nakaruma Y, Yashiro M, et al. Incidence survey of Kawasaki disease in 1997 and 1998 in Japan. Pediatrics 2001;107:e33.
8. Morens DM, Anderson U, Hurwotz ES. National surveillance of Kawasaki disease. Pediatrics 1980;65:21-5.
9. Taubert KA, Rowley AH, Shulman ST. Nationwide survey of Kawasaki disease and acute rheumatic fever. J Pediatr 1991;119:279-82.
10. Taubert KA, Rowley AH, Shulman ST. Seven year national survey of Kawasaki disease and acute rheumatic fever. Pediatr Infect Dis J 1994;13:704-8.
11. Bronstein DE, Besser RE, Burns JC. Passive surveillance for Kawasaki disease in San Diego County. Pediatr Infect Dis J 1997;16:1015-18.
12. Shulman ST, Innocencio J, Hirsch R. Kawasaki disease. Pediatr Clin North Am 1995;42:1205-22.
13. Fujita Y, Nakamura Y, Sakata K, et al. Kawasaki in families. Pediatrics 1989;84:66-9.
14. Royle JA, Williams K, Elliott E, et al. Kawasaki disease in Australia, 1993-95. Arch Dis Child 1998;78:33-9.
15. Levin M, Tizzard EJ, Dillon MJ. Kawasaki disease: recent advances. Arch Dis Child 1991;66:1369-74.
16. Curtis N. Kawasaki disease. BMJ 1997;315:322-3.
17. Leung DYM, Meissner HC, et al. Toxic shock syndrome toxin-secreting Staphlococcus aureus in Kawasaki syndrome. Lancet 1993;342:1385-8.
18. Curtis N, Zheng R, Lamb JR, et al. Evidence for a superantigen mediated process in Kawasaki disease. Arch Dis Child 1995;72:308-11.
19. Leung DYM, Giorno RC, Kazemi LV, et al. Evidence for superantigen sterantigen involvement in cardiovascular injury due to Kawasaki syndrome. J Immunol 1995;155:5018-21.
20. Furukawa S, Matsubara T, Jujoh K, et al. reduction of peripheral blood macrophages/monocytes in Kawasaki disease by intravenous gammaglobulin. Eur J Pediatr 1990;150:43-7.
21. Lee HK, Kim DS, Noh GW, et al. Effects of intravenous immune globulin on the peripheral lymphocyte phenotypes in Kawasaki disease. Yonsei Med J 1996;37:357-63.
22. Jason J, Montana E, Donald JF, et al. Kawasaki disease and the T cell antigen receptor. Human Immunol 1998;59:29-38.
23. Infections. In: McIntosh N, Helms P, Smyth R, eds. Forfar & Arneil's textbook of pediatrics. Edinburgh: Churchill Livingstone, 2003.
24. Krugman S, Ward R. Infectious disease of children. St Louis: Mosby, 1968.
25. Sireci G, Dieli F, Salerno A. T cells recognise an immunodominant epitope of heat shock protein 65 in Kawasaki disease. Mol Med 2000;6:581-90.
26. Brogan P, Bose A, Burgner D, et al. Kawasaki disease: an evidence based approach to diagnosis, treatment, and proposals for future research. Arch Dis Child 2002;86:286-90.
27. Yangawa H, Yashiro M, Nakamura Y, et al. Results of 12 nationwide epidemiological incidence surveys of Kawasaki disease in Japan. Arch Pediatr Adolesc Med 1995;149:779-83.
28. Kato H, Akagi T, Sugimura T, et al. Kawasaki disease. Coron Artery Dis 1995;6:194-206.
29. Yamakawa R. The vascular function of the long-term coronary artery after Kawasaki disease - evaluation by intracoronary injection of acetylcholine. Kurume Medical Journal 1997;44:7-14.
30. Wilt MT, Minnich LL, Bahnsack JF, et al. Kawasaki disease: more patients are being diagnosed who do not meet American Heart Association criteria. Pediatrics 1997;104:e10.
31. Umezawa T, Matsuo N, Saji T. Treatment of Kawasaki disease using the intravenous aspirin anti-inflammatory effect. Acta Paediatr Jpn 1992;34:548-58.
32. Shulman ST. High-dose aspirin in Kawasaki disease. J Pediatr 1999;134:523-4.
33. Love SAJL, Oates-Whitehead RM, Baumer JH, et al. Salicylate for treatment of Kawasaki disease in children (protocol for a Cochrane Review). In: The Cochrane Library, Issue 4. Chicester: John Wiley & Sons, Ltd, 2003 [Full review to be published Issue 2, 2004.
34. Furusho K, Kamiya T, Nakano H, et al. Intravenous gamma-globulin for Kawasaki disease. Acta Paediatr Jpn 1991;33:799-804.
35. Akagi T, Kato H, Inoue O, et al. Salicylate treatment in Kawasaki disease: high dose or low dose? Eur J Pediatr 1991;150:642-6.
36. Terai M, Shulman ST. Prevalence of coronary artery abnormalities in Kawasaki disease is highly dependent on gamma globulin dose but independent of salicylate dose. J Pediatr 1997;131:888-93.
37. Durangpisitkul K, Gururaj VJ, Park JM, et al. The prevention of coronary artery aneurysm in Kawasaki disease: a meta analysis on the efficacy of aspirin and immunoglobulin in treatment. Pediatrics 1995;96:1057-61.
38. Oates-Whitehead R, Baumer J, Haines L, et al. Intravenous immunoglobulin for the treatment of Kawasaki disease in children (Cochrane Review). In: The Cochrane Library, Issue 4. Chichester: John Wiley & Sons, Ltd, 2003.
39. Liu T, Wang X. Steroid hormone treatment for Kawasaki disease in children (Protocol for a Cochrane review). In: The Cochrane Library, Issue 4. Chicester: John Wiley & Sons, Ltd, 2003 [Full review to be published Issue issue 3, 2004.].
40. Murugan SJ, Thomson J, Parson M. Is life long follow up for patients with Kawasaki disease indicated? eLetter to Brogan PA, Bose A, Burgner D, et al. Kawasaki disease: an evidence based approach to diagnosis, treatment, and proposals for future research. Arch Dis Child 2002;86:286-90 [http:// adc.bmijournals.com/cgi/eletters/archdischild;86/4/286#326 published 29 July 2002].
41. Archer N. Follow up of Kawasaki disease. eLetter to Brogan PA, Bose A, Burgner D, et al. Kawasaki disease: an evidence based approach to diagnosis, treatment, and proposals for future research. Arch Dis Child 2002;86:286-90 [http://adc.bmjjournals.com/cgi/eletters/ archdischild;86/4/286#412 published 12 February 2003].
42. Tulloh R, Brogan PA, Bose A, et al. Kawasaki disease. Unknown outcome of long term follow-up. eLetter to Brogan PA, Bose A, Burgner D, et al. Kawasaki disease: an evidence based approach to diagnosis, treatment, and proposals for future research. Arch Dis Child 2002;86:286-90 [http:// adc.bmjjournals.com/cgi/ eletters/archdischild;86/4/286#425 published 20 February 2003].
43. Dhillon R, Clarkson P, Donald AE, et al. Endothelial dysfunction late after Kawasaki disease. Circulation 1996;94:2103-6.